NYSE$NHC

National HealthCare Corporation · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

NHC's earnings increased in Q3 2024 due to White Oak acquisition and overall revenue growth.

National HealthCare Corporation reported a strong third quarter in 2024, with a 17.9% increase in net operating revenues and grant income, primarily driven by the acquisition of White Oak Manor. GAAP net income attributable to NHC significantly increased, along with adjusted net income and diluted earnings per share.

  • Net operating revenues and grant income increased by 17.9% to $340.2 million compared to Q3 2023.
  • GAAP net income attributable to NHC was $42.8 million, a substantial increase from $10.4 million in the same period last year.
  • Adjusted net income rose by 50.3% to $19.9 million compared to $13.3 million in Q3 2023.
  • GAAP diluted earnings per share were $2.73, up from $0.68 in the prior year, while adjusted diluted earnings per share increased to $1.27 from $0.86.

Headline financials

Total Revenue

$340M

Previous: $288M+17.9%
EPS

$2.73

Previous: $0.86+217.4%
Capital Expenditures

-$19.4M

Previous: -$19.3M-0.7%
Free Cash Flow

$23.3M

Previous: -$8.91M+362.0%
Net Income

$42.8M

Previous: $10.4M+311.9%
Operating Income

$21M

Previous: $13M+61.6%
Gross Profit

$340M

Previous: $288M+17.9%
Cash & Equivalents

$84.8M

Previous: $100M-15.5%
Total Assets

$1.56B

Previous: $1.28B+21.9%
Stock-Based Comp

$1.09M

Previous: $708K+54.4%

Revenue & EPS history

NHC · Revenue · Quarterly

$340M

Q3 2024+17.9%vs Q3 2023

Revenue by segment

NHC · $260M total across 2 segments · Q1 2023

  • Net patient revenues
    $258M+2.8%
  • Other revenues
    $2.06M-87.5%

Forward guidance

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

+0.1%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+1.8%

Avg return

30 days after

60%

39 / 65 earnings

Positive

+12.2%

Q2 2023

Best reaction

-14.0%

Q4 2009

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%+11.8%+12.9%
Q4 2025+2.0%-4.7%-3.7%
Q3 2025+1.1%+3.4%+7.8%
Q1 2025+1.6%-3.1%-3.3%
Q4 2024+0.8%+0.1%-0.2%
Q3 2024+4.5%-0.1%-4.8%
Q2 2024+3.2%+3.7%+6.4%
Q1 2024+0.9%+4.4%+7.4%
Q4 2023+5.8%+7.1%-0.1%
Q3 2023+1.8%+3.9%+14.2%
Q2 2023+12.2%+12.6%+12.5%
Q1 2023+1.9%+5.4%+11.5%
Q4 2022-2.4%-3.9%-8.2%
Q3 2022-3.2%-1.0%-1.3%
Q2 2022+1.1%+1.9%+0.8%
Q1 2022+2.8%+0.8%+1.9%
Q4 2021+0.5%+0.4%+9.6%
Q3 2021+5.9%+1.3%-10.0%
Q2 2021-0.8%-2.4%-5.9%
Q1 2021-1.5%-1.6%+2.4%
Q4 2020+3.7%+10.3%+20.5%
Q3 2020-1.8%+13.0%+2.3%
Q2 2020+5.8%+5.0%-1.2%
Q1 2020-0.0%-5.0%+5.4%
Q4 2019-0.2%-8.4%-16.6%
Q3 2019-0.4%+0.1%+1.1%
Q2 2019-0.6%+0.4%-5.3%
Q1 2019+0.1%+1.4%+2.3%
Q4 2018+1.8%-0.2%-4.2%
Q3 2018-2.3%-3.5%-2.1%
Q2 2018+1.7%+4.4%+5.3%
Q1 2018+3.0%+3.8%+8.3%
Q4 2017-7.1%-2.5%-3.3%
Q3 2017-1.0%+2.9%+0.4%
Q2 2017+0.0%+2.3%-3.8%
Q1 2017-1.1%-1.2%-2.2%
Q4 2016+1.0%+0.8%+0.3%
Q3 2016-2.1%+1.0%+7.6%
Q2 2016+1.9%+2.6%+4.7%
Q1 2016-0.6%
Q4 2015-1.6%
Q3 2015+0.5%
Q2 2015-3.4%
Q1 2015+0.1%
Q4 2014+1.0%
Q3 2014+1.9%
Q2 2014+0.4%
Q1 2014+2.3%
Q4 2013-0.4%
Q3 2013+0.7%
Q2 2013+1.5%
Q1 2013-0.3%
Q4 2012+1.2%
Q3 2012+1.8%
Q2 2012-1.0%
Q1 2011-4.9%
Q1 2012+3.2%
Q4 2011-0.9%
Q3 2010+7.9%
Q3 2011+7.9%
Q4 2009-14.0%
Q4 2010-14.0%
Q2 2010-14.0%
Q2 2011-14.0%
Q1 2010+3.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro